Alcon AG | ALC - Gross Profit On Sales


Alcon AG reported $1.69B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AstraZeneca USD 12.61B 225M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
UCB EUR 3.19B 621M Dec/2025